Your Space
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Medicine > The Rising Cost of Prescription Drugs

Tags

  • conduct
  • paying
  • prescription
  • generic versions
  • saving drugs

  • Links

  • How To Pick Your Website Colors
  • Laptop Computer Sales
  • The Role Of Internet In Mystery Shopping
  • Your Space - The Rising Cost of Prescription Drugs

    If you’re like many Americans, the rising cost of prescription drugs may be costing you your health. In particular, seniors living on a fixed income with no insurance are finding it difficult to pay for necessary prescriptions out-of-pocket, and as a result, may be failing to receive the treatment they need to stay healthy. Often, the struggle can put a big strain on s
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    eniors’ finances.

    But why are prescription drug prices so high, especially when most people who require medication are usually not in a financial position that allows them to afford the full price tag? The real reasons are more complicated than what you might suspect, but one thing’s for certain - drug prices have been skyrocketing.

    The reason that is most often tout
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ed (by the drug companies, of course) for the high price of drugs is research and development (R&D) costs. The drug companies contest that the only way to pay for the development of new life-saving drugs - that will improve the lives of millions of Americans - is through profits from current drug sales. The high prices, they say, are merely a reflection of the spending
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    that is necessary for the creation of newer, better drugs.

    But is this the truth? Are drug companies using a large percentage of current prescription drug sales to fund R&D? If so, are the new drugs under development truly going to improve the health of the people who need them most? Sadly, this doesn’t appear to be the case.

    In reality, drug companies spend more on
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    advertising, lobbying and political contributions than they do on research and development. Most of the money you pay for prescription medication ends up in the pockets of marketers and politicians, so that you can be convinced that you need the "newer" and "better" drugs that are under development.

    In addition, research and development tends to focus on more "marketa
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ble" types of drugs that the drug companies can sell to the largest amounts of people. How many times have you seen advertisements for a drug that can help alleviate such serious medical conditions as social anxiety disorder and seasonal allergies? Unfortunately, this means that most large drug companies tend to neglect the development of life-saving drugs for more ser
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ious conditions, as the numbers are not there to rake in high profits.

    Developing new allergy or anxiety drugs, however, does not require massive amounts of money, as these drugs have already been developed. Neither does rehashing previously developed drugs to be marketed for a new ailment. Usually the newer drugs under "development" aren’t new at all. So even the mon
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    y that is spent on R&D, it can be argued, is an unnecessary expense driven by the market more than by the country’s medical needs.

    Unfortunately for the consumer, all the money spent on advertising rather than development, and providing drug information to physicians about specific new drugs that need to be marketed, makes it very likely that you will end up paying mo
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    re money than you should. Also, because your doctor is only provided with information on the latest and "greatest" drugs, he/she will be more likely to prescribe you the more expensive drugs. Perhaps surprisingly, there are older versions of drugs on the market that work just as well as their updated counterparts (sometimes better) as well as generic versions of brand
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    name drugs that come at a significantly reduced cost. Of course, the drug companies do not market these drugs and do all they can to keep generic drugs off the shelves for as long as possible.

    That’s another place your money goes when you buy prescription drugs - lawyers. Drug companies spend a lot of money paying for court cases to extend the patents of certain drugs
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    Even though the cases are often lost in the end, court processes can take months to resolve - buying more time for the drug companies to be the sole profiteers of a particular drug. When the patent on a drug runs out, other companies are allowed to create and sell a generic version of the drug. It is usually sold for a lower price, which takes customers away from the
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    brand name and reduces that drug company’s profits. In the end, patents are often extended anyway because the drug company finds a new application for the drug, thus artificially extending the life of the patent and keeping generics off the shelves. You end up paying more because a less expensive generic alternative is not available and you are forced to shell out for
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    the higher priced brand name drug instead.

    For the lucky people who have insurance that covers the cost of their drugs, this may be indirectly allowing the drug companies to charge more than they would if everyone had to pay full price. Because many people never see the true cost of their prescriptions, the price is not something they worry about. As a result, drug co
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    mpanies feel freer to raise prices and costs continue to rise. The bottom line? A large percentage of what you pay for drugs is taken as profit.

    What Can You Do To Lower Your Drug Costs?

    Understanding why drug costs are so high, you may feel that it is impossible to find a way to reduce them. But this simply isn’t true. There are several things you can do to make pre
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    cription drugs more affordable.

    As mentioned briefly above, it pays (literally) to be informed. If your doctor doesn’t possess the knowledge regarding all the drug choices available for your condition, take initiative and conduct some of your own research. Ask your doctor if there are any older versions of the newest drug you’ve been prescribed and find out if the dru
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    g is as effective. If it can do the job just as well as its newer relation, and comes with a cheaper price tag, it won’t take you long to make a decision.

    Secondly, find out if there are any generic versions of the drug you need available in your area. Generic drugs are the same drug but without the brand name price tag. This type of drug is similar to the no-name bra
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    nds you find in your local grocery store. The product is exactly the same but less expensive because you’re not paying for the name (and hence the advertising).

    If you are uninsured or underinsured, make sure you exhaust all your insurance options. Calculate the costs associated with purchasing an insurance plan and determine whether or not you can find a plan that wi
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    l ultimately weigh in your favor. Also, find out if you can benefit from Medicare. Medicare Part D is one option you should research, although for many Americans it has actually made prescription drugs more expensive and seems to have been created to benefit the drug companies rather than the American public. The process can be confusing, but if you take the time to fi
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    nd out if you are one of the lucky few to benefit, it could be worth your while.

    Finally, many Americans have chosen to order discount drugs online, from either American or Canadian pharmacies. American online pharmacies offer older and generic versions of drugs at a reduced cost, while Canadian operations can actually offer brand name prescriptions (or whatever presc
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ription you require) for a significantly lower price. This is simply because the Canadian Government regulates the cost of drugs, which means you pay less at the cash register. As long as the pharmacy is licensed to conduct international pharmacy services, ordering online from a Canadian pharmacy is a safe and affordable alternative to the high cost of drugs in the U.S


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.yourspace.org.ua/article/252868/yourspace-The-Rising-Cost-of-Prescription-Drugs.html">The Rising Cost of Prescription Drugs</a>

    BB link (for phorums):
    [url=http://www.yourspace.org.ua/article/252868/yourspace-The-Rising-Cost-of-Prescription-Drugs.html]The Rising Cost of Prescription Drugs[/url]

    Related Articles:

    Understanding the Basics of Managerial Accounting

    Payday Loan Companies - Are Their Rates Too High?

    Best Paid Online Surveys

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com